endpoints.news is our new home on June 1. endpts.com will still work, but the front door is now https://endpoints.news

Beam dis­clos­es first clin­i­cal da­ta on base-edit­ed sick­le cell ther­a­py, one pa­tient death

6 months ago
R&D
Cell/Gene Tx

Prog­nomiQ rais­es $34M for lung can­cer test

6 months ago
Deals
Diagnostics

Up­dat­ed: Ver­tex makes mon­ey from gene-edit­ed ther­a­py Cas­gevy

6 months ago
Pharma

Nek­tar di­vests man­u­fac­tur­ing site and reagent arm for $90M 

6 months ago
Deals
Manufacturing

Why hos­pi­tals have been slow to adopt AI for med­ical care

6 months ago
Startups
AI

Sana nar­rows fo­cus again to ze­ro in on di­a­betes and au­toim­mune dis­ease

6 months ago
R&D

Viking CEO on ‘shock­ing’ mar­ket re­ac­tion to oral obe­si­ty da­ta, prepar­ing for Phase 3

6 months ago
R&D
Manufacturing

FDA cites Mark Cuban's drug com­pound­ing cen­ter in Dal­las with steril­i­ty, qual­i­ty con­cerns

6 months ago
Pharma
FDA+

The elec­tion is Tues­day. What’s at stake for the phar­ma in­dus­try?

6 months ago
Pharma
FDA+

Rare dis­ease bio­phar­ma com­pa­nies weigh in on FDA's new in­no­va­tion hub

6 months ago
FDA+

BioN­Tech eas­es 2024 rev­enue out­look de­spite hefty Covid vac­cine third-quar­ter sales

6 months ago
Pharma

FDA ex­pands faster drug re­view pi­lot from sup­ple­men­tal to full ap­pli­ca­tions

6 months ago
Pharma
FDA+

BioN­Tech says VEGF bis­pe­cif­ic’s PD-L1 tar­get, com­bo plans will be its edge

6 months ago
R&D
Pharma

No­vo, As­cendis to work on month­ly GLP-1; KalVista makes a roy­al­ty deal

6 months ago
News Briefing

'We play to win': As­traZeneca de­tails first re­sults for oral GLP-1 and broad­er obe­si­ty am­bi­tions

6 months ago
R&D
Pharma

Is there room for MASH drugs in a GLP-1 world?

6 months ago
R&D
Pharma

Eu­ro­pean Com­mis­sion marks Dec. 6 for No­vo-Catal­ent deal de­ci­sion

6 months ago
Deals
Manufacturing

Viking's oral weight loss drug ap­pears to have strong ef­fect in Phase 1 tri­al

6 months ago
R&D
Pharma

No­vo adds to We­govy’s car­dio strength with hos­pi­tal ad­mis­sions analy­sis

6 months ago
Pharma

Cin­Rx touts pos­i­tive ear­ly-stage da­ta from two obe­si­ty can­di­dates

6 months ago
R&D

How RFK Jr. might in­flu­ence the FDA; Phar­ma's Q3 high­lights; Ab­b­Vie's lat­est neu­ro buy­out; and more

7 months ago
Weekly

BMS, J&J and As­traZeneca plea with ap­peals court to over­turn drug price ne­go­ti­a­tions

7 months ago
Pharma
Law

Ex­clu­sive: Women’s health uni­corn Maven Clin­ic cuts 10% of its work­force weeks af­ter rais­ing $125M

7 months ago
People
Health Tech

Her­itage and Apo­tex to pay $49.1M in price-fix­ing set­tle­ment

7 months ago
Pharma
Law
First page Previous page 78798081828384 Next page Last page
A service from the Financial Times